# Can you take a GLP-1 while breastfeeding? · PepVault

Source: https://pepvault.app/guides/glp-1-while-breastfeeding

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?

Reviewed November 2026 21 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Every GLP-1 label's breastfeeding line side by side, what milk studies measured for semaglutide and tirzepatide, why the pills differ, and ACOG's 2026 advice.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 21
- **Questions:** 7
- **Compounds:** 7

## The short answer

In the US, the labels for the GLP-1 shots (Ozempic, Wegovy, Mounjaro, Zepbound) leave it to you and your prescriber to weigh breastfeeding's benefits against your need for the drug. In milk studies, injected semaglutide was undetectable and tirzepatide mostly so. The semaglutide tablets and Foundayo are not recommended, and ACOG advises against any GLP-1 with a preterm baby or newborn. European and UK advice is mostly stricter.

Every number checked at its primary source · Nov 20, 2026 · [21 sources](https://pepvault.app/guides/glp-1-while-breastfeeding#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** US and European prescribing labels, one company lactation study for tirzepatide (11 women) and one for semaglutide tablets, one independent milk study of injected semaglutide (8 women), LactMed, and ACOG's 2026 practice advisory; no study has followed breastfed babies or milk supply over time, and the other GLP-1s have no human milk data.

## What does each GLP-1 label say about breastfeeding?

Every US label has a section 8.2, Lactation. For the injections it ends on the same sentence: "The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need" for the drug and any possible effect on the baby[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) [2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) [4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5). That is not a no. It hands the decision to you and your prescriber. Two pills are the exception, and they say so plainly. Here is each label as it stands on DailyMed on November 20, 2026:

| Medicine | Form | The label's line | Measured in human milk |
| --- | --- | --- | --- |
| Ozempic (semaglutide) | Weekly shot | Weigh the benefits of breastfeeding against the need for the drug[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) | No human data; in rats, milk levels 3 to 12 times lower than the mother's blood[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) |
| Wegovy shot (semaglutide) | Weekly shot | The same weighing; the label adds that the shot has no SNAC[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) | No human data on the label[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) |
| Wegovy tablets (semaglutide) | Daily pill | "Breastfeeding is not recommended"[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) | Semaglutide below the lowest measurable level; SNAC found in milk[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) |
| Rybelsus and Ozempic tablets (semaglutide) | Daily pill | "Breastfeeding is not recommended"[3](https://pepvault.app/guides/glp-1-while-breastfeeding#source-3) | Semaglutide below the lowest measurable level; SNAC found in milk[3](https://pepvault.app/guides/glp-1-while-breastfeeding#source-3) |
| Mounjaro and Zepbound (tirzepatide) | Weekly shot | The same weighing[4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5) | Undetectable in 164 of 171 samples from 11 women[4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5) |
| Saxenda and Victoza (liraglutide) | Daily shot | The same weighing[6](https://pepvault.app/guides/glp-1-while-breastfeeding#source-6) [7](https://pepvault.app/guides/glp-1-while-breastfeeding#source-7) | No human data; in rats, milk about half the mother's blood level[6](https://pepvault.app/guides/glp-1-while-breastfeeding#source-6) [7](https://pepvault.app/guides/glp-1-while-breastfeeding#source-7) |
| Trulicity (dulaglutide) | Weekly shot | The same weighing[8](https://pepvault.app/guides/glp-1-while-breastfeeding#source-8) | No human data; not measured in animals either[8](https://pepvault.app/guides/glp-1-while-breastfeeding#source-8) |
| Byetta (exenatide) | Twice-daily shot | The same weighing[9](https://pepvault.app/guides/glp-1-while-breastfeeding#source-9) | No human data; in mice, milk up to 2.5% of the blood level[9](https://pepvault.app/guides/glp-1-while-breastfeeding#source-9) |
| Foundayo (orforglipron) | Daily pill | "Not recommended for nursing women"[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10) | No human data; in rats, radio-labelled drug in milk at 3 times the blood level[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10) |

The rat, mouse and rabbit numbers are animal results. Two labels say outright that species differences in how milk is made leave their meaning for people unclear[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) [9](https://pepvault.app/guides/glp-1-while-breastfeeding#source-9).

<!--promo-->

PepVault keeps the date and amount of every dose you log, so when your prescriber or your baby's doctor asks when you last took it, or when a step-up began, the answer is on record. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-while-breastfeeding-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault keeps the date and amount of every dose you log, so when your prescriber or your baby's doctor asks when you last took it, or when a step-up began, the answer is on record.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How much semaglutide or tirzepatide gets into breast milk?

Very little, often nothing. Three measurements exist:

| Study | Who and how | What was found |
| --- | --- | --- |
| Tirzepatide, Lilly's lactation study[4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5) | 11 healthy women, one 5 mg shot, milk sampled for 28 days | None detectable in 164 of 171 samples (the test sees down to 4 ng/mL). The other 7 held less than 0.02% of the mother's dose in total; the last trace was on day 5 |
| Injected semaglutide, Diab 2024[11](https://pepvault.app/guides/glp-1-while-breastfeeding#source-11) | Milk from 8 women, taken 0, 12 and 24 hours after their weekly shot | None detected in any sample (the test sees down to 1.7 ng/mL). Worst-case relative infant dose: 1.26% |
| Semaglutide tablets, the label's lactation study[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) [3](https://pepvault.app/guides/glp-1-while-breastfeeding#source-3) | Women taking the tablet; the label gives no number | Semaglutide below the lowest level the test can count; SNAC and its breakdown products present |

The semaglutide study's worst case is a **relative infant dose**: the share of the mother's dose, per kilogram of body weight, a baby would get through milk if milk held the drug at the lowest level the test can count (5.7 ng/mL). Below 10% is the usual line for a medicine to count as compatible with breastfeeding, and 1.26% is well under it[11](https://pepvault.app/guides/glp-1-while-breastfeeding#source-11). The study was small, and it measured milk, not babies.

The reason is size. These drugs are peptides, chains of amino acids, and big ones: semaglutide weighs 4,114 daltons, tirzepatide 4,814, exenatide 4,187 and liraglutide 3,751, and dulaglutide is joined to part of an antibody at about 63,000[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) [4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [6](https://pepvault.app/guides/glp-1-while-breastfeeding#source-6) [8](https://pepvault.app/guides/glp-1-while-breastfeeding#source-8) [9](https://pepvault.app/guides/glp-1-while-breastfeeding#source-9). Foundayo's orforglipron, an ordinary pill-sized molecule, weighs 902[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10). Molecules that big pass poorly into milk[14](https://pepvault.app/guides/glp-1-while-breastfeeding#source-14) [15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15). What does get through is a protein in the baby's gut, which **LactMed**, the US National Library of Medicine's drugs-in-breastfeeding database, says is probably partly broken down there and poorly absorbed[13](https://pepvault.app/guides/glp-1-while-breastfeeding#source-13) [14](https://pepvault.app/guides/glp-1-while-breastfeeding#source-14). For injected semaglutide, LactMed adds that these mothers' breastfed babies had no adverse effects[12](https://pepvault.app/guides/glp-1-while-breastfeeding#source-12).

## Why are the semaglutide tablets and Foundayo not recommended?

Not because of the drug in the milk. Semaglutide tablets carry **SNAC** (salcaprozate sodium), a helper that lets the peptide be absorbed in the stomach. Semaglutide itself was below the measurable level in milk, but SNAC and its breakdown products were present. The labels explain that the enzymes that clear SNAC may work more slowly in babies, so SNAC could build up in newborns and infants, and since semaglutide shots without SNAC exist, they say not to breastfeed on the tablets[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2) [3](https://pepvault.app/guides/glp-1-while-breastfeeding#source-3). The Wegovy label makes the point itself: the shot "does not contain the SNAC metabolites"[2](https://pepvault.app/guides/glp-1-while-breastfeeding#source-2).

Foundayo is a different kind of molecule. Orforglipron is not a peptide but a small molecule of 902 daltons, the size of an ordinary pill, and in rats, radio-labelled orforglipron reached milk at 3 times its blood level[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10). The label's reasoning is direct: "When a drug is present in animal milk, it is likely that the drug will be present in human milk", so it is "not recommended for nursing women"[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10). ACOG reaches the same place from a different side and advises people who breastfeed to avoid oral GLP-1s[15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Semaglutide (oral)

- [Semaglutide (oral): the full reference](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025)
- [All 6 studies](https://pepvault.app/research#semaglutide-oral)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)

## What do ACOG and other health bodies say?

The same small studies are read in different ways. In October 2026 the American College of Obstetricians and Gynecologists (ACOG) published its advice on GLP-1s in pregnancy and lactation[15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15). Europe and the UK are stricter than the US labels, with one exception:

| Who | What they say about breastfeeding |
| --- | --- |
| ACOG, US obstetricians (October 2026)[15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15) | Shared decision-making on a postpartum plan that may include a GLP-1; if used, the baby's weight gain is watched closely with the baby's clinician; recommend against with preterm babies and "neonates" (in medicine, the first 28 days; ACOG gives no age); prefer shorter half-lives; avoid the oral forms |
| LactMed, US National Library of Medicine[12](https://pepvault.app/guides/glp-1-while-breastfeeding#source-12) [13](https://pepvault.app/guides/glp-1-while-breastfeeding#source-13) [14](https://pepvault.app/guides/glp-1-while-breastfeeding#source-14) | Semaglutide: only the injectable forms. Tirzepatide: "not a reason to discontinue breastfeeding", with caution for a newborn or preterm baby. Liraglutide: amounts in milk likely very low, same caution |
| European labels (EMA)[16](https://pepvault.app/guides/glp-1-while-breastfeeding#source-16) [17](https://pepvault.app/guides/glp-1-while-breastfeeding#source-17) [18](https://pepvault.app/guides/glp-1-while-breastfeeding#source-18) | Ozempic and Wegovy: "should not be used during breast-feeding". Mounjaro: tirzepatide "could be considered for use during breast-feeding" |
| MHRA, UK regulator (February 2026)[19](https://pepvault.app/guides/glp-1-while-breastfeeding#source-19) | GLP-1 medicines "should not be taken by people who are breastfeeding", because there is not enough safety data |

None of these rests on a study of breastfed babies over months. A 2026 review of diabetes medicines in breastfeeding found that only 5 of 20 had any data on transfer into milk, semaglutide among them, and that 4.4% of guideline recommendations were based on clinical evidence[20](https://pepvault.app/guides/glp-1-while-breastfeeding#source-20). So the advice is caution where the data are thinnest: the youngest and smallest babies, and the pills. Where you live decides which label you read, and your prescriber decides which applies to you.

## Does a GLP-1 affect milk supply or the baby's weight?

No one has measured it. The US labels that address it say there are no data on the effect on milk production or on the breastfed baby[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) [4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10). ACOG names the open question: a GLP-1 lowers your appetite, and eating too little could in theory change how much milk you make or what is in it in ways that hold back the baby's growth, and it asks for the baby's weight gain to be watched closely[15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15). Europe's Mounjaro label says the same: whether lower food intake changes the milk's nutrient content is not known[18](https://pepvault.app/guides/glp-1-while-breastfeeding#source-18).

**Commonly reported:** worry about supply in the first weeks on a dose, finding it hard to eat enough while nursing, and restarting after weaning or once the baby is on solid food.

<!--promo-->

PepVault's food log sets a daily protein target from your weight and counts each meal against it, so the days you ate too little show up before they add up. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-while-breastfeeding-inline&mt=8)

<!--/promo-->

**When to get help** Call your baby's doctor if your baby feeds less, has fewer wet diapers or stops gaining weight, and call your own prescriber if you cannot keep food or fluids down.

## Which GLP-1 clears fastest, and why does that matter?

A general rule for medicines while breastfeeding is to choose the one with the shorter **half-life**, the time the body takes to clear half of a dose, because a stop or a pause takes effect sooner. ACOG applies it to GLP-1s and names exenatide as the preferred choice if one is needed[15](https://pepvault.app/guides/glp-1-while-breastfeeding#source-15), but FDA's Drugs@FDA database lists Byetta, Bydureon and the one generic exenatide as discontinued[21](https://pepvault.app/guides/glp-1-while-breastfeeding#source-21). Among the GLP-1s still marketed in the US, liraglutide is the shortest-acting. From the labels:

| Drug (brand) | Half-life on the label | Given |
| --- | --- | --- |
| Exenatide (Byetta, discontinued in the US) | 2.4 hours[9](https://pepvault.app/guides/glp-1-while-breastfeeding#source-9) | Twice a day |
| Liraglutide (Saxenda, Victoza) | About 13 hours[6](https://pepvault.app/guides/glp-1-while-breastfeeding#source-6) [7](https://pepvault.app/guides/glp-1-while-breastfeeding#source-7) | Once a day |
| Orforglipron (Foundayo) | 29 to 49 hours[10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10) | Once a day, by mouth |
| Tirzepatide (Mounjaro, Zepbound) | About 5 days[4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5) | Once a week |
| Dulaglutide (Trulicity) | About 5 days[8](https://pepvault.app/guides/glp-1-while-breastfeeding#source-8) | Once a week |
| Semaglutide (Ozempic, Wegovy) | About 1 week; present for about 5 weeks after the last shot[1](https://pepvault.app/guides/glp-1-while-breastfeeding#source-1) | Once a week |

Try it

How Tirzepatide builds up

An estimate from a half-life of about 5 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Tirzepatide in the library](https://pepvault.app/peptides/tirzepatide)

Half-life is one input, not the answer: the weekly shots are the ones with milk data. If another pregnancy is possible, the stop-before dates and the birth-control pill rules are in our guide to GLP-1s and pregnancy. One rule carries into breastfeeding: tirzepatide and Foundayo can make birth-control pills less reliable, and their labels say to switch to a non-pill method or add condoms for 4 weeks (Foundayo: 30 days) after starting and after each dose increase[4](https://pepvault.app/guides/glp-1-while-breastfeeding#source-4) [5](https://pepvault.app/guides/glp-1-while-breastfeeding#source-5) [10](https://pepvault.app/guides/glp-1-while-breastfeeding#source-10).

## What should you ask your prescriber and your baby's doctor?

- Is my baby old enough and big enough, given ACOG's advice on newborns and preterm babies?
- Which drug and form, a shot rather than a pill, fits what I take it for: diabetes, weight or both?
- Should I start lower or step up more slowly while I nurse, to protect what I eat?
- Who weighs the baby, and how often, while I am on it?
- If I take a birth-control pill, what do I use for the weeks after each step-up?

For the first months on a dose, what to eat and how to keep protein up is in our guide to what to eat on a GLP-1.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information (DailyMed, setid adec4fd2, SPL version 20, effective Jun 1, 2026): sections 8.2, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, setid ee06186f, SPL version 19, revised 06/2026): section 8.2. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Novo Nordisk. RYBELSUS and OZEMPIC (oral semaglutide) tablets, prescribing information (DailyMed, setid 27f15fac, SPL version 14, revised 1/2026): section 8.2. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98)
4. Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information (DailyMed, setid d2d7da5d, SPL version 40, effective Aug 27, 2026): sections 7.2, 8.2, 8.3, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
5. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information (DailyMed, setid 487cd7e7, SPL version 40, revised 08/2026): sections 8.2, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
6. Novo Nordisk. SAXENDA (liraglutide) injection, prescribing information (DailyMed, setid 3946d389, SPL version 22, revised 02/2026): sections 8.2, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
7. Novo Nordisk. VICTOZA (liraglutide) injection, prescribing information (DailyMed, setid 5a9ef4ea, SPL version 31, effective Oct 14, 2025): sections 8.2 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4)
8. Eli Lilly and Company. TRULICITY (dulaglutide) injection, prescribing information (DailyMed, setid 463050bd, SPL version 62, effective Jun 16, 2026): sections 8.2, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309)
9. AstraZeneca. BYETTA (exenatide) injection, prescribing information (DailyMed, setid 53d03c03, SPL version 26, effective Sep 2, 2025): sections 8.2, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f)
10. Eli Lilly and Company. FOUNDAYO (orforglipron) tablets, prescribing information (DailyMed, setid 8ac446c5, SPL version 10, effective Jul 29, 2026): sections 8.2, 8.3, 11 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62)
11. Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K. Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk. Nutrients. 2024;16(17):2886. [PubMed 39275201](https://pubmed.ncbi.nlm.nih.gov/39275201/)
12. Drugs and Lactation Database (LactMed). Semaglutide. National Institute of Child Health and Human Development; updated Aug 15, 2026. [PubMed 30000039](https://pubmed.ncbi.nlm.nih.gov/30000039/)
13. Drugs and Lactation Database (LactMed). Tirzepatide. National Institute of Child Health and Human Development; updated Aug 15, 2026. [PubMed 35759552](https://pubmed.ncbi.nlm.nih.gov/35759552/)
14. Drugs and Lactation Database (LactMed). Liraglutide. National Institute of Child Health and Human Development; updated Aug 15, 2026. [PubMed 30000036](https://pubmed.ncbi.nlm.nih.gov/30000036/)
15. American College of Obstetricians and Gynecologists. Use of glucagon-like peptide-1 receptor agonists in pregnancy and lactation. Practice Advisory, October 2026. [acog.org](https://www.acog.org/clinical/guidance/practice-advisory/2026/10/use-of-glucagon-like-peptide-1-receptor-agonists-in-pregnancy-and-lactation)
16. European Medicines Agency. Ozempic: EPAR product information (summary of product characteristics), section 4.6. Read Nov 20, 2026. [ema.europa.eu](https://www.ema.europa.eu/en/documents/product-information/ozempic-epar-product-information_en.pdf)
17. European Medicines Agency. Wegovy: EPAR product information (summary of product characteristics), section 4.6. Read Nov 20, 2026. [ema.europa.eu](https://www.ema.europa.eu/en/documents/product-information/wegovy-epar-product-information_en.pdf)
18. European Medicines Agency. Mounjaro: EPAR product information (summary of product characteristics), section 4.6. Read Nov 20, 2026. [ema.europa.eu](https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf)
19. Medicines and Healthcare products Regulatory Agency. GLP-1 medicines for weight loss and diabetes: what you need to know. GOV.UK, updated Feb 5, 2026. [gov.uk](https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know)
20. Richardson K, Kiptoo J, Mpora Odongkara B, Ojara FW, Waitt C. Maternal-to-infant transfer of medications for type 2 diabetes mellitus via breastmilk: a systematic review of available evidence and clinical guidelines. Clin Pharmacol Ther. 2026;119(5):1223-1234. [PubMed 41670332](https://pubmed.ncbi.nlm.nih.gov/41670332/)
21. US Food and Drug Administration. Drugs@FDA (openFDA): BYETTA (NDA021773), BYDUREON (NDA022200), BYDUREON BCISE (NDA209210) and exenatide (ANDA206697), marketing status Discontinued. Read Nov 20, 2026. [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)

Eloralintide, petrelintide and amycretin side by side: the doses their trials used, weight loss vs placebo, side effects and phase 3 status as of Nov 2026.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Semaglutide (oral) Studied range: 1.5–25 mg](https://pepvault.app/peptides/semaglutide-oral)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)
- [Dulaglutide Studied range: 0.75–4.5 mg](https://pepvault.app/peptides/dulaglutide)
- [Exenatide Studied range: 5–10 mcg](https://pepvault.app/peptides/exenatide)
- [Orforglipron Studied range: 0.8–17.2 mg](https://pepvault.app/peptides/orforglipron)

## Related guides

- Guide · GLP-1s

  ### [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)

  Ozempic, Wegovy, Mounjaro and Zepbound in pregnancy: each label's stop-before line, the pill warning, breastfeeding, wash-out times and what 2026 studies found.

  Read the guide
- Guide · GLP-1s

  ### [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)

  What to eat on Ozempic, Wegovy or Zepbound: protein first, small regular meals, fiber and fluids, what to limit, and what the trials' diet programmes asked for.

  Read the guide
- Guide · GLP-1s

  ### [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)

  The Wegovy pill is daily semaglutide, FDA approved in December 2025. How to take it, its doses beside the weekly shot's, and OASIS 4 next to STEP 1.

  Read the guide
- Guide · GLP-1s

  ### [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)

  Foundayo (orforglipron) is a daily GLP-1 pill, not a peptide. Its ATTAIN and ACHIEVE results beside Zepbound's SURMOUNT and Wegovy's STEP, in one table.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Semaglutide (oral)

- [Semaglutide (oral): the full reference](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025)
- [All 6 studies](https://pepvault.app/research#semaglutide-oral)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
